Autolus Therapeutics Ltd
Biotechnology
Healthcare
AUTL
266 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
2.27
52 week high
4.80
high
2.32
52 week low
1.32
previous Close
2.27
P/E ratio
market cap
580 M
div yield
0
net incoming
-82.09 M
-40.88 %
net profit margin
-8209400000.00 %
0.00 %
operating incoming
-67.88 M
-15.18 %
net change in cash
-48.42 M
7.92 %
cash on hand
657 M
-6.92 %
cost of revenue
223 K
-88.23 %
top